Literature DB >> 16569788

Transition zone prostate cancers: features, detection, localization, and staging at endorectal MR imaging.

Oguz Akin1, Evis Sala, Chaya S Moskowitz, Kentaro Kuroiwa, Nicole M Ishill, Darko Pucar, Peter T Scardino, Hedvig Hricak.   

Abstract

PURPOSE: To retrospectively evaluate the accuracy of endorectal magnetic resonance (MR) imaging in the detection and local staging of transition zone prostate cancers, with pathologic analysis serving as the reference standard, and to assess MR imaging features of these cancers.
MATERIALS AND METHODS: The institutional review board approved this HIPAA-compliant retrospective study and waived the informed consent requirement. An institutional database of 986 patients who underwent MR imaging before radical prostatectomy yielded 148 consecutive patients with at least one transition zone cancer at step-section pathologic analysis. An additional 46 patients without transition zone cancer were randomly selected as a control group. Two readers independently reviewed MR studies to identify patients with transition zone cancers and determine the location and local extent of these cancers. Imaging features that helped in the identification of transition zone cancers were recorded. Descriptive and kappa statistics, as well as receiver operating characteristic and multivariate logistic regression analyses, were used.
RESULTS: For identification of patients with transition zone cancers, sensitivity and specificity were 75% and 87%, respectively, for reader 1 and 80% and 78%, respectively, for reader 2. Interreader agreement was fair. For detection of the location of transition zone cancer, the area under the receiver operating characteristic curve was 0.75 for reader 1 and 0.73 for reader 2. Interreader agreement was fair. The readers' accuracy in detecting transition zone cancer foci increased significantly (P=.001) as tumor volume increased. In the detection of extraprostatic extension of transition zone cancers, sensitivity and specificity were 56% and 94%, respectively, for reader 1 and 28% and 93%, respectively, for reader 2. Homogeneous low T2 signal intensity (P=.001 for reader 1, P<.001 for reader 2) and lenticular shape (P=.017 for reader 1) were significantly associated with the presence of transition zone cancer.
CONCLUSION: MR imaging can be used to detect, localize, and stage transition zone prostate cancers. Copyright (c) RSNA, 2006.

Entities:  

Mesh:

Year:  2006        PMID: 16569788     DOI: 10.1148/radiol.2392050949

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  109 in total

1.  MRI findings of prostate stromal tumour of uncertain malignant potential: a case report.

Authors:  V F Muglia; G Saber; G Maggioni; A J C Monteiro
Journal:  Br J Radiol       Date:  2011-10       Impact factor: 3.039

2.  Simultaneous Segmentation of Prostatic Zones Using Active Appearance Models With Multiple Coupled Levelsets.

Authors:  Robert Toth; Justin Ribault; John Gentile; Dan Sperling; Anant Madabhushi
Journal:  Comput Vis Image Underst       Date:  2013-09-01       Impact factor: 3.876

3.  Prostate biopsy: targeting cancer for detection and therapy.

Authors:  Samir S Taneja
Journal:  Rev Urol       Date:  2006

4.  Computed diffusion-weighted imaging using 3-T magnetic resonance imaging for prostate cancer diagnosis.

Authors:  Yoshiko Ueno; Satoru Takahashi; Kazuhiro Kitajima; Tokunori Kimura; Ikuo Aoki; Fumi Kawakami; Hideaki Miyake; Yoshiharu Ohno; Kazuro Sugimura
Journal:  Eur Radiol       Date:  2013-07-25       Impact factor: 5.315

5.  A Multireader Exploratory Evaluation of Individual Pulse Sequence Cancer Detection on Prostate Multiparametric Magnetic Resonance Imaging (MRI).

Authors:  Sonia Gaur; Stephanie Harmon; Rajan T Gupta; Daniel J Margolis; Nathan Lay; Sherif Mehralivand; Maria J Merino; Bradford J Wood; Peter A Pinto; Joanna H Shih; Peter L Choyke; Baris Turkbey
Journal:  Acad Radiol       Date:  2018-04-25       Impact factor: 3.173

Review 6.  Role of magnetic resonance imaging and magnetic resonance spectroscopic imaging before and after radiotherapy for prostate cancer.

Authors:  Antonio C Westphalen; David A McKenna; John Kurhanewicz; Fergus V Coakley
Journal:  J Endourol       Date:  2008-04       Impact factor: 2.942

7.  Validation of the Dominant Sequence Paradigm and Role of Dynamic Contrast-enhanced Imaging in PI-RADS Version 2.

Authors:  Matthew D Greer; Joanna H Shih; Nathan Lay; Tristan Barrett; Leonardo Kayat Bittencourt; Samuel Borofsky; Ismail M Kabakus; Yan Mee Law; Jamie Marko; Haytham Shebel; Francesca V Mertan; Maria J Merino; Bradford J Wood; Peter A Pinto; Ronald M Summers; Peter L Choyke; Baris Turkbey
Journal:  Radiology       Date:  2017-07-19       Impact factor: 11.105

8.  Diagnosis of Prostate Cancer with Noninvasive Estimation of Prostate Tissue Composition by Using Hybrid Multidimensional MR Imaging: A Feasibility Study.

Authors:  Aritrick Chatterjee; Roger M Bourne; Shiyang Wang; Ajit Devaraj; Alexander J Gallan; Tatjana Antic; Gregory S Karczmar; Aytekin Oto
Journal:  Radiology       Date:  2018-02-02       Impact factor: 11.105

9.  Influence of imaging and histological factors on prostate cancer detection and localisation on multiparametric MRI: a prospective study.

Authors:  Flavie Bratan; Emilie Niaf; Christelle Melodelima; Anne Laure Chesnais; Rémi Souchon; Florence Mège-Lechevallier; Marc Colombel; Olivier Rouvière
Journal:  Eur Radiol       Date:  2013-03-15       Impact factor: 5.315

Review 10.  New horizons in prostate cancer imaging.

Authors:  Gregory Ravizzini; Baris Turkbey; Karen Kurdziel; Peter L Choyke
Journal:  Eur J Radiol       Date:  2008-11-07       Impact factor: 3.528

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.